Strategic Projects
Initiatives
Useful Links
News
02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
01/2026
Interview with Nataša Jenčić, general manager at Biogen...
Innovative Pharmaceutical Initiative – iF!
19
innovative pharmaceutical companies
703
employees
56
% of the Croatian medicines market
32
M Eur of transferred value in 2024
30
years of the Association’s activity
Board of Directors
Schalk Opperman
— President
Merck
Ivan Lolić
— Vice President
Novartis
Tatjana Tomljanović
Johnson & Johnson
Rina Musić
MSD
Marin Dumičić
Astellas
Velimir Šimičević
Servier
Paula Seijas Romero
Boehringer Ingelheim
Executive Director
Sani Pogorilić
— Executive Director
iF!
Task Forces
Medical and Regulatory
Velimir Šimičević, Sponsor
Ethics and Compliance
Velimir Šimičević, Sponsor
Pricing & Reimbursement
Rina Musić, Sponsor
Žanina Jakopin, Secretary
Žanina Jakopin, Secretary
Finance and Tax
Schalk Opperman, Sponsor
Igor Šalat, Head
Igor Šalat, Head
Patients
Tatjana Tomljanović, Sponsor
Andreja Šantek, Head
Nikolina Škaron, Secretary
Daniela Ćutić, Secretary
Andreja Šantek, Head
Nikolina Škaron, Secretary
Daniela Ćutić, Secretary
EU Policies
Vaccines
Rina Musić, Sponsor
Iva Jović, Head
Iva Jović, Head
Oncology
Ljiljana Vnučec, Secretary
Cardiovascular Health
Velimir Šimičević, Sponsor
Damir Gašparović, Head
Marija Strgačić, Secretary
Damir Gašparović, Head
Marija Strgačić, Secretary
Rare Diseases
Vesna Tomljenović, Head